Blog

CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.23 per share a year ago. These figures are

XPeng Inc. XPEV announced that its second-generation Vision-Language-Action autonomous driving system, VLA 2.0, is scheduled for global deployment starting in 2027, marking an important development

Shake Shack Inc.’s SHAK recent performance highlights how operational efficiency is becoming a key driver of its profitability and EBITDA growth. In 2025, the company reported revenue growth of

Sandisk SNDK is benefiting from a shift in NAND flash demand tied to artificial intelligence (AI) infrastructure buildouts. The result is a more constructive supply-demand balance and a better

U.S. consumer prices rose moderately in February, with the Consumer Price Index (CPI) rising 0.3% for the month, according to data released by the U.S. Labor Department. The reading, which left the

The escalating U.S.–Israel conflict with Iran has plunged global energy markets into turmoil, with the Strait of Hormuz — through which about 20% of the world’s crude oil passes — now effectively a

Viasat, Inc. VSAT, through its Inmarsat Maritime unit, is deploying the NexusWave connectivity service across the expanding fleet of gas carriers operated by EXMAR. The rollout aims to support

The Campbell's Company CPB reported second-quarter fiscal 2026 results, with the top and bottom lines missing the Zacks Consensus Estimate. Both net sales and earnings experienced year-over-year

Walmart Inc.’s WMT fourth-quarter fiscal 2026 results highlighted a strong 24% surge in global eCommerce sales, underscoring the retailer’s steady transition into a tech-powered omnichannel leader

Wall Street expects a year-over-year decline in earnings on lower revenues when Monte Rosa Therapeutics (GLUE) reports results for the quarter ended December 2025. While this widely-known consensus

Arcos Dorados (ARCO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Scholastic (SCHL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook gives

Darden Restaurants (DRI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended February 2026. This widely-known consensus

The market expects FedEx (FDX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook is

Signet (SIG) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook gives a

Wall Street expects a year-over-year increase in earnings on higher revenues when Accenture (ACN) reports results for the quarter ended February 2026. While this widely-known consensus outlook is

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 12:

ADMA Biologics, Inc. ADMA: This biopharmaceutical company has a Zacks Rank #1 and

Investors in Kura Oncology Inc. KURA need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2026 $17.00 Call had some of the highest

Papa John's PZZA is strengthening the digital ecosystem and loyalty platform as part of its ongoing transformation strategy. The company is focusing on improving the digital ordering experience and

Domino's Pizza, Inc. DPZ relies on strong same-store sales to support overall retail growth across its global system. The company focuses on driving higher order volumes, strengthening store-level

The price trend for Health Catalyst (HCAT) has been bearish lately and the stock has lost 6.5% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session

Shares of GT Biopharma, Inc. (GTBP) have been struggling lately and have lost 6.6% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean

Remitly Global, Inc. (RELY) closed the last trading session at $16.98, gaining 28.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Shares of Bentley Systems, Incorporated (BSY) have gained 14% over the past four weeks to close the last trading session at $38.66, but there could still be a solid upside left in the stock if

Shares of ANI Pharmaceuticals (ANIP) have gained 0.1% over the past four weeks to close the last trading session at $76.29, but there could still be a solid upside left in the stock if short-term